GC Therapeutics
Cambridge, US · 43 employees on LinkedIn · 4 known investors
GCTx develops an induced pluripotent stem cell (iPSC) programming platform called TFome™ that uses synthetic biology, gene editing, and machine learning to improve cell therapy development and scaling. The platform is designed to expand patient access to cell therapies across various therapeutic areas.
Founders & leadership
GC
George ChurchCo-Founder & Scientific Advisor
PK
Parastoo KhoshakhlaghChief Executive Officer & Co-Founder
AN
Alex NgChief Innovation Officer & Co-Founder
Investors · 4
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ASep 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does GC Therapeutics do?
- GCTx develops an induced pluripotent stem cell (iPSC) programming platform called TFome™ that uses synthetic biology, gene editing, and machine learning to improve cell therapy development and scaling. The platform is designed to expand patient access to cell therapies across various therapeutic areas.
- Who founded GC Therapeutics?
- GC Therapeutics was founded by George Church, Parastoo Khoshakhlagh, Alex Ng.
- Who are GC Therapeutics's investors?
- GC Therapeutics's investors include Andreessen Horowitz, Global Brain, Medical Excellence Capital, Humboldt.
- Where is GC Therapeutics headquartered?
- GC Therapeutics is headquartered in Cambridge, US.